propionylcarnitine has been researched along with Coronary Disease in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 10 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kotaka, K; Miyazaki, Y; Ogawa, K; Ozawa, T; Satake, T; Sugiyama, S | 1 |
| Bartels, GL; Kruijssen, DA; Pillay, M; Remme, WJ; Schönfeld, DH | 1 |
| Angelini, C; Brevetti, G; Carrozzo, R; De Amicis, V; Di Lello, F; Fanin, M; Martone, VD | 1 |
| Bartels, GL; Cox, PH; Knufman, NM; Kruijssen, HA; Pillay, M; Remme, WJ; Schönfeld, DH | 1 |
| Lagioia, R; Mangini, SG; Mastropasqua, F; Ramunni, G; Ricci, A; Rizzon, P; Scrutinio, D; Totaro Fila, G; Valentini, G | 1 |
| Bhatnagar, R; Leipälä, JA; Massoumi, K; Najibi, S; Packer, L; Pineda, E | 1 |
| Bezstarosti, K; Lamers, JM; Sassen, LM; Van der Giessen, WJ; Verdouw, PD | 1 |
| Chiddo, A; Gaglione, A; Grimaldi, N; Locuratolo, N; Musci, S; Rizzon, P; Troito, G | 1 |
| Boffa, GM; Cargnoni, A; Ceconi, C; Curello, S; Ferrari, R; Pasini, E; Visioli, O | 1 |
| Paulson, D; Regitz, V; Shug, A; Subramanian, R | 1 |
| Corr, PB; Dobmeyer, DJ; Kanter, EM; Priori, SG; Yamada, KA | 1 |
| Caiati, C; Chiddo, A; Galantino, A; Ricci, A; Rizzon, P; Scrutinio, D; Valentini, G | 1 |
| Di Lisa, F; Miotto, G; Pivetta, A; Siliprandi, D; Siliprandi, N | 1 |
| Liedkte, AJ; Molaparast-Saless, F; Nellis, SH | 1 |
| Noonan, J; Paulson, DJ; Schmidt, M; Shug, AL; Traxler, J | 1 |
1 review(s) available for propionylcarnitine and Coronary Disease
| Article | Year |
|---|---|
Transport and function of L-carnitine and L-propionylcarnitine: relevance to some cardiomyopathies and cardiac ischemia.
Topics: Animals; Biological Transport; Cardiomyopathies; Carnitine; Coronary Disease; Humans; Myocardium; Sarcolemma | 1987 |
4 trial(s) available for propionylcarnitine and Coronary Disease
| Article | Year |
|---|---|
Effects of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris.
Topics: Aged; Angina Pectoris; Cardiac Output; Cardiotonic Agents; Carnitine; Coronary Disease; Electrocardiography; Exercise Test; Heart; Heart Rate; Humans; Hypoxanthine; Hypoxanthines; Lactates; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Placebos; Stroke Volume; Ventricular Function, Left; Ventricular Pressure | 1994 |
Changes in skeletal muscle histology and metabolism in patients undergoing exercise deconditioning: effect of propionyl-L-carnitine.
Topics: Carnitine; Conditioning, Psychological; Coronary Disease; Exercise; Glycogen; Humans; Male; Middle Aged; Muscle Fibers, Skeletal; Muscle, Skeletal; Reference Values | 1997 |
Propionyl-L-carnitine: a new compound in the metabolic approach to the treatment of effort angina.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Carnitine; Coronary Disease; Double-Blind Method; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption | 1992 |
[Acute effects of propionyl-L-carnitine on anomalies of parietal kinetics of the left ventricle induced by atrial pacing in patients with ischemic heart disease. A bidimensional echocardiographic study].
Topics: Adult; Cardiac Pacing, Artificial; Carnitine; Coronary Disease; Double-Blind Method; Echocardiography; Heart; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Stroke Volume | 1989 |
10 other study(ies) available for propionylcarnitine and Coronary Disease
| Article | Year |
|---|---|
Reversal of ischemia-induced mitochondrial dysfunction after coronary reperfusion.
Topics: Acyl Coenzyme A; Adenosine Diphosphate; Animals; Carnitine; Coronary Circulation; Coronary Disease; Dogs; Female; Lipids; Male; Mitochondria, Heart; Oxygen Consumption; Perfusion | 1982 |
Acute improvement of cardiac function with intravenous L-propionylcarnitine in humans.
Topics: Aged; Angina Pectoris; Blood Pressure; Carnitine; Coronary Disease; Female; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption; Stroke Volume | 1992 |
Protection of the reperfused heart by L-propionylcarnitine.
Topics: Animals; Blood Pressure; Carnitine; Coronary Circulation; Coronary Disease; Female; In Vitro Techniques; L-Lactate Dehydrogenase; Magnetic Resonance Imaging; Mitochondria, Heart; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Phosphocreatine; Phosphorus Isotopes; Rats; Rats, Inbred Strains; Ventricular Function, Left | 1991 |
L-propionylcarnitine increases postischemic blood flow but does not affect recovery of energy charge.
Topics: Adenosine Triphosphate; Animals; Calcium; Calcium-Binding Proteins; Carnitine; Coronary Circulation; Coronary Disease; Energy Metabolism; Female; Heart; Hemodynamics; Male; Myocardial Reperfusion; Myocardium; Phosphates | 1991 |
Hemodynamic study of intravenous propionyl-L-carnitine in patients with ischemic heart disease and normal left ventricular function.
Topics: Adult; Carnitine; Coronary Disease; Female; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Pulmonary Circulation | 1991 |
The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria.
Topics: Adenosine Triphosphate; Animals; Carnitine; Coronary Disease; Heart; Mitochondria, Heart; Myocardial Reperfusion Injury; Rabbits | 1991 |
Protective effects of propionyl-L-carnitine during ischemia and reperfusion.
Topics: Acetylcarnitine; Acyl Coenzyme A; Animals; Carnitine; Coronary Disease; Hemodynamics; Male; Myocardial Reperfusion; Rats; Rats, Inbred Strains | 1991 |
Delineation of the influence of propionylcarnitine on the accumulation of long-chain acylcarnitines and electrophysiologic derangements evoked by hypoxia in canine myocardium.
Topics: Animals; Carnitine; Coronary Disease; Dogs; Electrophysiology; Heart; Hypoxia; Membrane Potentials; Myocardium | 1991 |
The effects of propionylcarnitine taurine on cardiac performance in aerobic and ischemic myocardium.
Topics: Animals; Carnitine; Coronary Disease; Heart; Oxygen; Perfusion; Swine; Taurine | 1988 |
Protection of the ischaemic myocardium by L-propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation.
Topics: Acetylcarnitine; Adenosine Triphosphate; Animals; Blood Pressure; Cardiac Output; Carnitine; Coronary Disease; Fatty Acids; Male; Myocardial Contraction; Myocardium; Oxidation-Reduction; Palmitic Acid; Palmitic Acids; Phosphocreatine; Rats; Rats, Inbred Strains | 1986 |